Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
673.82
-2.72 (-0.40%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Thermo Fisher Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Operating Revenue
47,35246,33745,19844,55743,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,211
Other Revenue
-1-1-1-1----------------
47,35146,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,211
Revenue Growth (YoY)
8.27%7.23%5.36%3.91%3.22%2.04%0.95%0.05%-2.42%-2.71%-3.00%-4.58%-1.69%1.64%6.53%14.55%13.08%11.95%14.57%21.70%
Cost of Revenue
27,85427,34426,69726,25425,63525,36425,12325,13025,05025,03625,25825,75726,03526,16626,11925,94424,55622,86021,23819,573
Gross Profit
19,49718,99218,50018,30218,10117,84817,77517,74917,32017,31017,23417,10017,38617,35817,68818,97119,61119,96019,88519,638
Selling, General & Admin
8,8428,7738,6018,5278,4708,4538,5028,6028,5208,4698,4348,4408,4648,6538,7818,9408,8548,6118,3177,857
Research & Development
1,4041,4021,3911,3971,4151,4151,4011,3901,3431,3161,3221,3371,4011,4331,4531,4711,4721,4721,4501,406
Amortization of Goodwill & Intangibles
139-------------------
Other Operating Expenses
20202120303030301111----3333
Operating Expenses
10,40510,19510,0139,9449,9159,8989,93310,0229,8649,7869,7579,7789,86510,08610,23410,41110,32910,0869,7709,266
Operating Income
9,0928,7978,4878,3588,1867,9507,8427,7277,4567,5247,4777,3227,5217,2727,4548,5609,2829,87410,11510,372
Interest Expense
-1,537-1,467-1,470-1,419-1,371-1,380-1,330-1,390-1,463-1,461-1,434-1,375-1,254-1,077-895-726-625-576-553-536
Interest & Investment Income
9519321,0239939621,0051,0021,0781,1601,1291,012879720542400272133744943
Earnings From Equity Investments
-64-52-35-41237-79-42-76-79-11-59-88-143-178-172-142-73-23-4
Currency Exchange Gain (Loss)
66526366227--16-16-37-58-2962881261024719-22162
Other Non Operating Income (Expenses)
-67-74-96-89-41-29-105-1113335-17-27-60-35-22-1118-161
EBT Excluding Unusual Items
8,4418,1887,9727,8687,7817,5607,4257,3627,0507,0897,0196,7436,9446,6556,8478,0018,6739,3079,5849,876
Merger & Restructuring Charges
-201-294-240-201-115-118-85-1108-171-90-220-388-104-232-68-82-67-52-72
Gain (Loss) on Sale of Investments
-89-13-40-382091121-689-46-58-83-64-161-93-58-7466
Gain (Loss) on Sale of Assets
72-----------141414-----
Asset Writedown
-94-154-108-94-252-252-252-252-219-219-219-219-60-60-60-46-12-12-122-122
Legal Settlements
---------19-19-1-19---18-----
Other Unusual Items
-292-141-196-267-315-179-111-26-5491-204--205-394-7-63-708-747-731-911
Pretax Income
7,8377,5867,3887,2687,1197,0206,9886,9956,7606,7796,5146,2396,2476,0286,4807,6637,7788,4238,6058,837
Income Tax Expense
7435985225475444364716576405945192843243024487037339739941,109
Earnings From Continuing Operations
7,0946,9886,8666,7216,5756,5846,5176,3386,1206,1855,9955,9555,9235,7266,0326,9607,0457,4507,6117,728
Net Income to Company
7,0946,9886,8666,7216,5756,5846,5176,3386,1206,1855,9955,9555,9235,7266,0326,9607,0457,4507,6117,728
Minority Interest in Earnings
-22-21-18-17-5--3-31535394018-5-8-10-13-11-8-3
Net Income
7,0726,9676,8486,7046,5706,5846,5146,3356,1356,2206,0345,9955,9415,7216,0246,9507,0327,4397,6037,725
Net Income to Common
7,0726,9676,8486,7046,5706,5846,5146,3356,1356,2206,0345,9955,9415,7216,0246,9507,0327,4397,6037,725
Net Income Growth (YoY)
7.64%5.82%5.13%5.83%7.09%5.85%7.95%5.67%3.26%8.72%0.17%-13.74%-15.52%-23.09%-20.77%-10.03%-17.90%-13.46%-4.05%21.18%
Shares Outstanding (Basic)
372374376377379380381382383384385386388389391392393393394394
Shares Outstanding (Diluted)
374375377378379381382383384386387388389391392394396396397397
Shares Change (YoY)
-1.52%-1.44%-1.38%-1.31%-1.30%-1.30%-1.36%-1.29%-1.16%-1.41%-1.34%-1.52%-1.71%-1.14%-1.07%-0.76%-0.50%-0.63%-0.44%-0.50%
EPS (Basic)
19.0218.6318.2417.7817.3417.3317.1016.5816.0216.2015.6715.5315.3314.7115.4317.7317.9218.9319.3219.61
EPS (Diluted)
18.9718.5818.1917.7417.3217.3017.0616.5315.9516.1315.5915.4515.2614.6415.3417.6317.7918.7919.1919.46
EPS Growth (YoY)
9.54%7.45%6.67%7.32%8.54%7.24%9.37%6.99%4.56%10.18%1.64%-12.37%-14.23%-22.09%-20.03%-9.40%-17.43%-12.99%-3.46%21.93%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Free Cash Flow
7,5967,3186,7486,2936,1116,1706,7247,2677,7757,9637,5606,9276,5465,8545,6206,9115,6006,3367,0016,789
Free Cash Flow Per Share
20.3419.5217.9216.6516.1116.2217.6118.9720.2320.6619.5417.8516.8414.9714.3317.5414.1616.0217.6617.10
Dividend Per Share
0.4301.8001.7601.7201.6801.6401.6001.5601.5201.4801.4401.4001.3501.3001.2501.2001.1601.1201.0801.040
Dividend Growth (YoY)
-74.41%9.76%10.00%10.26%10.53%10.81%11.11%11.43%12.59%13.85%15.20%16.67%16.38%16.07%15.74%15.38%16.00%16.67%17.39%18.18%
Gross Margin
41.17%40.99%40.93%41.08%41.39%41.30%41.44%41.39%40.88%40.88%40.56%39.90%40.04%39.88%40.38%42.24%44.40%46.61%48.35%50.08%
Operating Margin
19.20%18.98%18.78%18.76%18.72%18.40%18.28%18.02%17.60%17.77%17.60%17.09%17.32%16.71%17.02%19.06%21.02%23.06%24.60%26.45%
Profit Margin
14.94%15.04%15.15%15.05%15.02%15.24%15.19%14.77%14.48%14.69%14.20%13.99%13.68%13.14%13.75%15.47%15.92%17.37%18.49%19.70%
Free Cash Flow Margin
16.04%15.79%14.93%14.12%13.97%14.28%15.67%16.95%18.35%18.80%17.79%16.16%15.08%13.45%12.83%15.39%12.68%14.80%17.03%17.31%
EBITDA
12,19711,73911,29611,13810,99010,83310,81910,83510,66110,83210,86010,72810,93610,67210,83511,94112,49812,88012,94512,964
EBITDA Margin
25.76%25.34%24.99%25.00%25.13%25.07%25.22%25.27%25.16%25.58%25.56%25.03%25.19%24.52%24.73%26.59%28.30%30.08%31.48%33.06%
D&A For EBITDA
3,1052,9422,8092,7802,8042,8832,9773,1083,2053,3083,3833,4063,4153,4003,3813,3813,2163,0062,8302,592
EBIT
9,0928,7978,4878,3588,1867,9507,8427,7277,4567,5247,4777,3227,5217,2727,4548,5609,2829,87410,11510,372
EBIT Margin
19.20%18.98%18.78%18.76%18.72%18.40%18.28%18.02%17.60%17.77%17.60%17.09%17.32%16.71%17.02%19.06%21.02%23.06%24.60%26.45%
Effective Tax Rate
9.48%7.88%7.07%7.53%7.64%6.21%6.74%9.39%9.47%8.76%7.97%4.55%5.19%5.01%6.91%9.17%9.42%11.55%11.55%12.55%
Revenue as Reported
44,55646,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,211
SEC Filings: 10-K · 10-Q